Statin therapy is associated with lower all-cause mortality in patients with non-obstructive coronary artery disease

Atherosclerosis

Volumn 239, Issue 2, 2015, Pages 335-342

  Hwang, In Chang ^a,b   Jeon, Joo Yeong ^c   Kim, Younhee ^d   Kim, Hyue Mee ^a,b   Yoon, Yeonyee E ^a,e   Lee, Seung Pyo ^a,b   Kim, Hyung Kwan ^a,b   Sohn, Dae Won ^a,b   Sung, Jidong ^f   Kim, Yong Jin ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d Seoul National University   (South Korea)

^e Seoul National University Bundang Hospital   (South Korea)

^f Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Atherosclerosis; Coronary artery disease; Coronary computed tomography angiography; Statin

Indexed keywords

C REACTIVE PROTEIN; HIGH SENSITIVITY C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG;

ADULT; AGE; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MORTALITY; CHOLESTEROL BLOOD LEVEL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHY SCANNER; CORONARY ARTERY CALCIUM SCORE; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; NON OBSTRUCTIVE CORONARY ARTERY DISEASE; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION; SEX DIFFERENCE; AGED; CALCINOSIS; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY OBSTRUCTION; CORONARY BLOOD VESSEL; ELECTRONIC MEDICAL RECORD; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; RADIOGRAPHY; RISK FACTOR; SOUTH KOREA; TREATMENT OUTCOME;

AGED; CALCINOSIS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; CORONARY VESSELS; ELECTRONIC HEALTH RECORDS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; MALE; MIDDLE AGED; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; REPUBLIC OF KOREA; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84922519071     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.01.036     Document Type: Article

References (33)

1. Expert Panel on Detection, E and Treatment of High Blood Cholesterol in, A Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment Panel III). JAMA J. Am. Med. Assoc. 2001, 285:2486-2497.
2. Schuijf J.D., Wijns W., Jukema J.W., et al. Relationship between noninvasive coronary angiography with multi-slice computed tomography and myocardial perfusion imaging. J.Am. Coll. Cardiol. 2006, 48:2508-2514.
3. Min J.K., Dunning A., Lin F.Y., et al. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: an International Multicenter Registry) of 23,854 patients without known coronary artery disease. J.Am. Coll. Cardiol. 2011, 58:849-860.
4. Hoffmann U., Bamberg F., Chae C.U., et al. Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial. J.Am. Coll. Cardiol. 2009, 53:1642-1650.
5. Maddox T.M., Stanislawski M.A., Grunwald G.K., et al. Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA J. Am. Med. Assoc. 2014, 312:1754-1763.
6. Jespersen L., Hvelplund A., Abildstrom S.Z., et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur. Heart J. 2012, 33:734-744.
7. Hulten E.A., Carbonaro S., Petrillo S.P., et al. Prognostic value of cardiac computed tomography angiography: a systematic review and meta-analysis. J.Am. Coll. Cardiol. 2011, 57:1237-1247.
8. Bittencourt M.S., Hulten E., Ghoshhajra B., et al. Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events. Circ. Cardiovasc. Imaging 2014, 7:282-291.
9. Cheezum M.K., Hulten E.A., Smith R.M., et al. Changes in preventive medical therapies and CV risk factors after CT angiography. JACC. Cardiovasc. Imaging 2013, 6:574-581.
10. Hulten E., Bittencourt M.S., Singh A., et al. Coronary artery disease detected by coronary computed tomographic angiography is associated with intensification of preventive medical therapy and lower low-density lipoprotein cholesterol. Circ. Cardiovasc. Imaging 2014, 7:629-638.
11. Pitt B., Mancini G.B., Ellis S.G., et al. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation. J.Am. Coll. Cardiol. 1995, 26:1133-1139.
12. Schartl M., Bocksch W., Koschyk D.H., et al. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation 2001, 104:387-392.
13. Nissen S.E., Tuzcu E.M., Schoenhagen P., et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA J. Am. Med. Assoc. 2004, 291:1071-1080.
14. Nissen S.E., Nicholls S.J., Sipahi I., et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA J. Am. Med. Assoc. 2006, 295:1556-1565.
15. Nicholls S.J., Tuzcu E.M., Sipahi I., et al. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA J. Am. Med. Assoc. 2007, 297:499-508.
16. Kwon S. Payment system reform for health care providers in Korea. Health Policy Plan. 2003, 18:84-92.
17. Lee C.H., Kim K., Hyun M.K., et al. Use of inhaled corticosteroids and the risk of tuberculosis. Thorax 2013, 68:1105-1113.
18. Lee Y.K., Ha Y.C., Park C., et al. Bisphosphonate use and increased incidence of subtrochanteric fracture in South Korea: results from the National Claim Registry. Osteoporos. Int. J. Establ. Result Coop. Between Eur. Found. Osteoporos. Natl. Osteoporos. Found. U. S. A. 2013, 24:707-711.
19. Hulten E., Bittencourt M.S., Ghoshhajra B., et al. Incremental prognostic value of coronary artery calcium score versus CT angiography among symptomatic patients without known coronary artery disease. Atherosclerosis 2014, 233:190-195.
20. Agatston A.S., Janowitz W.R., Hildner F.J., et al. Quantification of coronary artery calcium using ultrafast computed tomography. J.Am. Coll. Cardiol. 1990, 15:827-832.
21. Rosner B. Fundamentals of Biostatistics 2010, Cengage Learning.
22. Choi E.K., Choi S.I., Rivera J.J., et al. Coronary computed tomography angiography as a screening tool for the detection of occult coronary artery disease in asymptomatic individuals. J.Am. Coll. Cardiol. 2008, 52:357-365.
23. Little W.C., Constantinescu M., Applegate R.J., et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?. Circulation 1988, 78:1157-1166.
24. Taylor F., Huffman M.D., Macedo A.F., et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 2013, 1:CD004816.
25. Baigent C., Keech A., Kearney P.M., et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005, 366:1267-1278.
26. Mihaylova B., Emberson J., et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012, 380:581-590. Cholesterol Treatment Trialists, C.
27. Waters D., Higginson L., Gladstone P., et al. Effects of cholesterol lowering on the progression of coronary atherosclerosis in women. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) substudy. Circulation 1995, 92:2404-2410.
28. Teo K.K., Burton J.R., Buller C.E., et al. Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: the Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). Circulation 2000, 102:1748-1754.
29. Ridker P.M., Danielson E., Fonseca F.A., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N.Engl. J. Med. 2008, 359:2195-2207.
30. Lauer M.S., Blackstone E.H., Young J.B., et al. Cause of death in clinical research: time for a reassessment?. J.Am. Coll. Cardiol. 1999, 34:618-620.
31. Shaw L.J., O'Rourke R.A. The challenge of improving risk assessment in asymptomatic individuals: the additive prognostic value of electron beam tomography?. J.Am. Coll. Cardiol. 2000, 36:1261-1264.
32. Pen A., Yam Y., Chen L., et al. Discordance between Framingham Risk Score and atherosclerotic plaque burden. Eur. Heart J. 2013, 34:1075-1082.
33. Hoffmann H., Frieler K., Schlattmann P., et al. Influence of statin treatment on coronary atherosclerosis visualised using multidetector computed tomography. Eur. Radiol. 2010, 20:2824-2833.